PainReform Statistics
Total Valuation
PainReform has a market cap or net worth of $1.75 million. The enterprise value is -$2.51 million.
Market Cap | 1.75M |
Enterprise Value | -2.51M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PainReform has 3.47 million shares outstanding. The number of shares has increased by 85.82% in one year.
Shares Outstanding | 3.47M |
Shares Change (YoY) | +85.82% |
Shares Change (QoQ) | +29.01% |
Owned by Insiders (%) | 6.29% |
Owned by Institutions (%) | 14.63% |
Float | 1.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.95 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.04.
Current Ratio | 1.61 |
Quick Ratio | n/a |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 63.98 |
Financial Efficiency
Return on equity (ROE) is -203.10% and return on invested capital (ROIC) is -663.18%.
Return on Equity (ROE) | -203.10% |
Return on Assets (ROA) | -145.40% |
Return on Capital (ROIC) | -663.18% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, PainReform has paid $8,000 in taxes.
Income Tax | 8,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.90% in the last 52 weeks. The beta is 0.61, so PainReform's price volatility has been lower than the market average.
Beta (5Y) | 0.61 |
52-Week Price Change | -92.90% |
50-Day Moving Average | 0.62 |
200-Day Moving Average | 1.73 |
Relative Strength Index (RSI) | 43.55 |
Average Volume (20 Days) | 138,471 |
Short Selling Information
The latest short interest is 52,154, so 1.50% of the outstanding shares have been sold short.
Short Interest | 52,154 |
Short Previous Month | 119,108 |
Short % of Shares Out | 1.50% |
Short % of Float | 3.72% |
Short Ratio (days to cover) | 0.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.73M |
Pretax Income | -12.53M |
Net Income | -12.54M |
EBITDA | -12.72M |
EBIT | -12.73M |
Earnings Per Share (EPS) | -$7.66 |
Balance Sheet
The company has $4.33 million in cash and $72,000 in debt, giving a net cash position of $4.26 million or $1.23 per share.
Cash & Cash Equivalents | 4.33M |
Total Debt | 72,000 |
Net Cash | 4.26M |
Net Cash Per Share | $1.23 |
Equity (Book Value) | 1.85M |
Book Value Per Share | 0.53 |
Working Capital | 1.99M |
Cash Flow
In the last 12 months, operating cash flow was -$8.42 million and capital expenditures -$16,000, giving a free cash flow of -$8.44 million.
Operating Cash Flow | -8.42M |
Capital Expenditures | -16,000 |
Free Cash Flow | -8.44M |
FCF Per Share | -$4.16 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PainReform does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -85.82% |
Shareholder Yield | -85.82% |
Earnings Yield | -716.09% |
FCF Yield | -481.77% |
Analyst Forecast
The average price target for PainReform is $2.00, which is 296.04% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.00 |
Price Target Difference | 296.04% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:10.
Last Split Date | Jul 3, 2023 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |